(ADTX)
NCM – Real vaqt narxi. Valyuta: USD
0.81
-0.07 (-7.95%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
0.82
+0.01 (1.49%)
Bozordan keyin: Mar 27, 2026, 7:59 PM EDT

NCM – Real vaqt narxi. Valyuta: USD
0.81
-0.07 (-7.95%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
0.82
+0.01 (1.49%)
Bozordan keyin: Mar 27, 2026, 7:59 PM EDT
Aditxt, Inc., tijoriy bosqichdagi kompaniya, immunitet salomatligi, aniq tibbiyot, aholi salomatligi, ayollar salomatligi va nevrologik salomatlik sohalarida mahsulotlarni kashf etadi va ishlab chiqadi. Kompaniya AditxtScore-ni ishlab chiqadi, bu esa odamlarga immunitet tizimidagi hujumlardan xabardor bo'lish uchun immunitet profillarini tushunish, boshqarish va kuzatish imkonini beradi; va Apoptotic DNA Immunotherapy, nuklein kislotasiga asoslangan texnologiya, bu organizm o'z to'qimalariga tabiiy ravishda tolerantlikni qanday keltirib chiqarishini taqlid qiluvchi yondashuvdan foydalanadi. Shuningdek, u teri ko'chirish, psoriaz, 1-toifa diabet va ko'p skleroz uchun ADI-100-ni ishlab chiqadi. Aditxt, Inc. Loma Linda universiteti va Leland Stanford Junior universiteti bilan litsenzion kelishuvga ega. Kompaniya ilgari ADiTx Therapeutics, Inc. nomi bilan tanilgan va 2021-yil iyul oyida Aditxt, Inc. nomini o'zgartirgan. Aditxt, Inc. 2017-yilda ro'yxatga olingan va shtab-kvartirasi Mountain View, Kaliforniyada joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Dolly B. Tyan D(ABHI), Ph.D. | Senior Vice President of Clinical Development Transplantation |
| Dr. Shahrokh Shabahang D.D.S., M.S., Ph.D. | Co-Founder, Chief Innovation Officer, Secretary & Director |
| Mr. Amro A. Albanna | Co-Founder, Chairman, CEO & President |
| Mr. Christopher J. Porcelli | General Counsel |
| Mr. Ge Chen M.D., M.S. | Senior Vice President of Preclinical Research & Discovery |
| Mr. Thomas J. Farley CPA | Chief Financial Officer |
| Ms. Corinne D. Pankovcin CPA, M.B.A. | Chief Mergers & Acquisitions Officer |
| Ms. Jennifer Lee | Director of Human Resources |
| Ms. Rowena Albanna | Chief Operating Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-03-13 | 8-K | ea0279443-8k_aditxt.htm |
| 2026-03-05 | 8-K | ea0280063-8k_aditxt.htm |
| 2026-01-30 | 8-K | ea0274881-8k_aditxt.htm |
| 2026-01-28 | 8-K | ea0274343-8k_aditxt.htm |
| 2025-12-16 | DEF 14A | ea0269766-def14a_aditxt.htm |
| 2025-12-05 | 8-K | ea0268358-8k_aditxt.htm |
| 2025-11-18 | DEFA14A | ea0266125-8kdef14a_aditxt.htm |
| 2025-11-17 | NT 10-Q | ea0265950-nt10q_aditxt.htm |
| 2025-11-14 | PRE 14A | ea0265449-pre14a_aditxt.htm |
| 2025-10-31 | 8-K | ea0263285-8k_aditxt.htm |